First slide

Abbott to strengthen endovascular product portfolio, has announced the acquisition of Walk Vascular, LLC. California based Walk Vascular, is a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to remove peripheral blood clots.

  • Walk Vascular’s JETi Peripheral Thrombectomy System and next-generation JETi AIO (All In One) Peripheral Thrombectomy System are unique aspiration systems for the removal of intravascular clots, known as thrombus, that can reduce blood flow and lead to serious complications for patients.
  • The innovative JETi systems are designed to break-up and remove clots from the peripheral vascular system while reducing the risk of dislodged clots.

In July 2021, Abbott, the leading health science company has announced an investment in research and development in Ireland. The investment at Clonmel Research and Development Centre is supported by the Irish government through IDA Ireland.

• Abbott invest at its cardiovascular Research and Development Centre based at its Vascular devices site in Clonmel, Co. Tipperary, Ireland.

• Abbott’s manufacturing plant in Clonmel manufactures its XIENCE family of stents, including XIENCE Sierra, for global use

In April 2021, Abbott announced that its new imaging platform powered by Ultreon 1.0 Software, is now CE Marked in Europe. This first-of-its-kind imaging software merges optical coherence tomography (OCT) – an imaging tool that provides physicians a comprehensive view inside an artery or blood vessel – with the power of artificial intelligence (AI) for enhanced visualization.

In Feb 2020, Abbott and Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod Insulin Management System (Omnipod System), announced to integrate Abbott’s world-leading1 glucose sensing technology with Insulet’s next-generation tubeless system, the Omnipod Horizon™ Automated Insulin Delivery (AID) System (Omnipod Horizon System), to offer personalized automated insulin delivery and care for people living with diabetes.

About Abbott:
Abbott, headquartered at Abbott Park, Illinois, United States, is a global medical devices and health care company. The company involves in businesses and products manufacturing related to diagnostics, medical devices, nutritionals and branded generic medicines. The company has more than 109,000 employees who serve people in more than 160 countries.

Prominent Global Investors

View all

Related News